Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01174784 · ClinicalTrials.gov registry record · NA
Chronic Total Occlusion Crossing With the Wildcat Catheter
A NA study, sponsored by Avinger.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01174784: Completed NA study, sponsored by Avinger.
NCT01174784 is a NA study that has completed, run by Avinger. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01174784, a NA study, has completed, sponsored by Avinger.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized study of the Wildcat Catheter to cross a single femoropopliteal chronic total occlusion (CTO). Safety and efficacy will be evaluated during the index procedure through 30-day follow-up.
Primary Outcome
The primary safety endpoint of the CONNECT Study was defined as absence of in-hospital or 30-days Major Adverse Events (MAEs), no evidence of clinically significant perforations, clinically significant embolizations or Grade C or greater dissections after Wildcat CTO crossing confirmed by angiography.
Interventions
- DEVICE Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01174784 record still lists
NCT01174784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer is the first listed.
NCT01174784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01174784 about?
NCT01174784 is a clinical study titled "Chronic Total Occlusion Crossing With the Wildcat Catheter". This is a prospective, multi-center, non-randomized study of the Wildcat Catheter to cross a single femoropopliteal chronic total occlusion (CTO). Safety and efficacy will be evaluated during the index procedure through 30-day follow-up.
What is the current status of trial NCT01174784?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2010-08. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01174784?
The interventions under investigation include: Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer (DEVICE).
Who is sponsoring clinical trial NCT01174784?
This trial is sponsored by Avinger, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01174784's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia